Europe’s next chapter will be written by the choices we make today. And policy will be the driving force behind whether we ...

ARE's steep dividend cut underscores deep strain from collapsing life science demand and forces it into asset sales and ...

As biotech firms shed jobs and life sciences funding dries up, policymakers have started to see defense technology as a way ...

Bluejay Capital Partners has completed a recapitalization of Quality Life Science Logistics & Transportation (QLS), a premier ...

Unlike traditional distributors, neutral platforms don’t own inventory or profit from supplier selection. A neutral platform ...

Investors and young scientists are pulling back from biotech, amid broader attacks on science under Trump, industry ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

After fighting against animal testing for decades with little success, campaigners now see a real prospect of rapidly ...

Aptyx is a Tempe, Arizona-based designer, developer and manufacturer of complex devices and components for the life sciences industry.

Aptyx acquires Argos Corp to create new Precision Extrusion Center of Excellence adding capacity and advanced technologies ...

ZAGENO earns global recognition for driving innovation, operational efficiency, and transformative customer value across the ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ('Tiziana” or the 'Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its ...